Jecure

02/15/2017 JLABS @ San Diego
00:11:33
Jecure

Jecure

Introducing JLABS @ San Diego resident Jecure Therapeutics. Jecure Therapeutics is focused on the discovery of innovative therapeutics for the treatment of non-alcoholic steatohepatitis (NASH) and liver fibrosis. Jecure’s academic founder is Dr. Ariel Feldstein, Division Chief of Gastroenterology at UCSD School of Medicine and a leading physician-scientist in hepatology. With operations in the biotech hub of San Diego, California, Jecure combines emerging NASH biology from Dr. Feldstein’s lab with an elite discovery team of veteran pharma/biotech scientists.


Related content